From: First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602
Level
Panitumumab
0
6 mg/Kg
-1
4.8 mg/Kg
-2
3.6 mg/Kg